The FOURIER study has finally revealed its results ! The study yielded the positive result that the antibody PCSK9 evolocumab (Repatha®, Amgen)…
Pilot treatment pathways in the Vendée and Loire-Atlantique for familial Hypercholesterolemia
Anhet-f used world familial hypercholesterolemia day to bring its members together on 23 September 2017 in Paris.
Led by the Nantes University Hospital as part of the CHOPIN project, the SAFIR study, which looks at familial hypercholesterolemia, has taken on its first patients